Stanley-Laman Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-41,069
Closed -$11.9M 293
2021
Q3
$11.9M Buy
41,069
+1,349
+3% +$346K 1.54% 12
2021
Q2
$7.93M Buy
39,720
+2,791
+8% +$541K 1.13% 24
2021
Q1
$7.18M Buy
36,929
+1,194
+3% +$245K 1.18% 24
2020
Q4
$6.85M Buy
+35,735
New +$6.5M 1.21% 23

Other funds holding RGEN

Stanley-Laman Group's RGEN Position: Q4 2021 in Review

Stanley-Laman Group sold out of Repligen (RGEN) in Q4 2021, closing a stake of 41,069 shares — an estimated $11.9M sold.

Stanley-Laman Group first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $11.9M in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Stanley-Laman Group reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Stanley-Laman Group sold 41,069 Repligen shares in Q4 2021, an estimated $11.9M.
  • Stanley-Laman Group first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
  • Stanley-Laman Group's Repligen position peaked at $11.9M in Q3 2021.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Stanley-Laman Group's 13F filing for Q4 2021, filed 25 Jan 2022.